热门资讯> 正文

Satellos Bioscience GAAP每股收益为-1.70美元

2026-03-27 19:06

Satellos Bioscience Inc(MSLE) 0

Satellos Bioscience press release (MSLE): FY GAAP EPS of -$1.70.
Satellos had cash and cash equivalents and short-term investments of $27.7 million as of Dec. 31, 2025, compared with $48.5 million on Dec. 31, 2024. The decrease primarily reflects cash used to fund ongoing operations, particularly clinical trial costs and supporting operating activities.

More on Satellos Bioscience Inc.

Satellos prices $50M public offering
Satellos launches public offering, applies for Nasdaq listing
Historical earnings data for Satellos Bioscience Inc.
Financial information for Satellos Bioscience Inc.

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。